InvAscent looks to exit Aizant Drug at $350-400 mn valuation

The investment firm has approached PE funds to buy a controlling stake in the drug development company

Related Keywords

China , Hyderabad , Andhra Pradesh , India , Australia , Russia , Canada , Brazil , Varma Rudraraju , Zephyr Peacock , India Life Sciences Fund , Reuters , Pearl Lane , India Ratings , India Life Sciences , Mordor Intelligence , Invascent , Aizant Drug Research , Aizant , Drug Development , Pharma Industry , Hope Fund , Stake Sale , Secondary Sale , Rothschild , Contract Manufacturing Operations ,